Univariate analysis | Multivariate analysis | ||||||
---|---|---|---|---|---|---|---|
HR | 95% CI | p value | HR | 95% CI | p value | ||
Age | < 65 | 1 | 0.34 | ||||
≧ 65 | 1.33 | 0.46–3.82 | |||||
Sex | Male | 1 | 0.58 | ||||
Female | 0.7 | 0.20–2.50 | |||||
Tumor site | Non-OCC | 1 | 0.01 | 1 | 0.009 | ||
OCC | 5.29 | 1.41–19.8 | 5.24 | 1.51–18.2 | |||
T stage | T1‑2 | 1 | 0.44 | ||||
T3‑4 | 0.63 | 0.23–1.90 | |||||
N stage | N0‑1 | 1 | 0.58 | ||||
N2a‑3 | 1.42 | 0.41–4.92 | |||||
Extracapsular extension | No | 1 | 0.69 | ||||
Yes | 1.3 | 0.37–4.59 | |||||
Positive/closed margin | No | 1 | 0.21 | ||||
Yes | 2.7 | 0.58–12.5 | |||||
Boost irradiation | No | 1 | 0.53 | ||||
Yes | 1.46 | 0.45–4.75 | |||||
Concurrent chemotherapy | No | 1 | 0.33 | 1 | 0.34 | ||
Yes | 0.57 | 0.19–1.76 | 0.62 | 0.23–1.66 |